| The Expression of MUC1 and CD44s in Non-small Cell Lung Cancer. |
|
Hye Kyung Park, Ji Seok Lee, Jun Hee Lee, Jung Wook Lee, Yun Seong Kim, Min Ki Lee, Young Dae Kim, Hyung Ryul Lee, Kun Il Kim, Cang Hun Lee, Soon Kew Park |
1Department of Internal Medicine, Pusna National University College of Medicine, Pusan, Korea. leemk98@yahoo.com
2Department of Thoracic Surgery, Pusna National University College of Medicine, Pusan, Korea.
3Department of Radiology, Pusna National University College of Medicine, Pusan, Korea.
4Department of Pathology, Pusna National University College of Medicine, Pusan, Korea. |
|
|
| Abstract |
BACKGROUND
MUC1 mucin is a heavily glycosylated large glycoprotein and is expressed aberrantly in carcinoma. CD44 is polymorphic family of cell surface glycoproteins participating in cell-cell adhesion and modulat ion of the cell-matrix interaction. MUC1 mucin and CD44 expression have been implicated in a tumor invasion and metastasis in certain malignancies. In this study, the expression of MUC1 and the standard form of CD44(CD44s) was examined in non-small cell lung cancer (NSCLC). METHODS: Immunohistochemical staining using monoclonal antibodies including MUC1 glycoprotein and CD44s was performed on 80 NSCLC surgical specimens. The association between MUC1 and CD44s expression and the histological type and tumor stage was investigated. RESULTS: Depolarized MUC1 expression in more than 10% of cancer cells was found in 12 (27.9%) out of 43 squamous cell carcinomas (SCCs) and 12 (32.4%) out of 37 adenocarcinomas (ACs). It was not associated with the tumor histological type and the TNM-stage in SCCs. Depolarized MUC1 expression correlated with the N-stage in ACs (p=0.036). CD44s was expressed in 36 (83.7%) out of 43 SCCs and 14(37.8%) out of 37ACs. Reduced CD44s expression correlated with the N-stage (p=0.031) and the TNM-stage (p=0.0006) in SCCs. CONCLUSIONS: Depolarized MUC1 expression was related to the nodal stage in NSCLC adenocarcinoma. Reduced CD44s expression was related to nodal involvement and the TNM-stage in squamous cell carcinoma. This suggests that MUC1 and CD44s expression in NSCLC might play important roles in tumor progression and can be used as prognostic variables. |
| Key Words:
MUC1, CD44s, Immunohistochemistry, NSCLC |
|
PDF Links
Full text via DOI
Download Citation
